Clover Health to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Clover Health (Nasdaq: CLOV) has announced its participation in several upcoming investor conferences in November and December 2024. CFO Peter Kuipers will present at the UBS Global Healthcare Conference on November 12 at 5:00 p.m. ET and the Citi Global Healthcare Conference on December 3 at 3:15 p.m. ET. He will also participate in the Canaccord Genuity Medical Technology Forum on November 21. CEO Andrew Toy will join the Virtual BTIG Digital Health Forum on November 25. Live webcasts and replays of the fireside chat presentations will be available on Clover Health's investor relations website.

FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences:

• CFO, Peter Kuipers, will present at the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024, at 5:00 p.m. Eastern Time.
• CFO, Peter Kuipers, will participate in the Canaccord Genuity 2024 Medical Technology, Diagnostics, and Digital Health & Services Forum on Thursday, November 21, 2024.
• CEO, Andrew Toy, will participate in the Virtual BTIG Digital Health Forum on Monday, November 25, 2024.
• CFO, Peter Kuipers, will present at the 2024 Citi Global Healthcare Conference on Tuesday, December 3, 2024, at 3:15 p.m. Eastern Time.

A live webcast and reply of the fireside chat presentations will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.

Press Contact:
Andrew Still-Baxter
press@cloverhealth.com

Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com

FAQ

Which investor conferences will Clover Health (CLOV) attend in November-December 2024?

Clover Health will attend four conferences: UBS Global Healthcare Conference (Nov 12), Canaccord Genuity Medical Technology Forum (Nov 21), BTIG Digital Health Forum (Nov 25), and Citi Global Healthcare Conference (Dec 3).

When will Peter Kuipers present at the UBS Global Healthcare Conference 2024?

Peter Kuipers will present at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, at 5:00 p.m. Eastern Time.

Where can I watch Clover Health's (CLOV) investor conference presentations?

Live webcasts and replays of the fireside chat presentations will be available on Clover Health's investor relations website at investors.cloverhealth.com.

Which Clover Health executives are participating in the 2024 investor conferences?

CFO Peter Kuipers will attend three conferences (UBS, Canaccord Genuity, and Citi), while CEO Andrew Toy will participate in the BTIG Digital Health Forum.